Xlcea Pharmaceutical Private Limited

Xlcea Pharmaceutical Private Limited - pharma in Gurgaon, Haryana, India. FY 2026 financials & compliance.
CIN U85100HR2020PTC091652 Incorporated 17 December 2020 ROC Delhi HQ Gurgaon, Haryana, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹2.3 Cr
▼ 12% YoY
Net profit · FY 2025
₹16.25 Lakh
Net margin 7.1%
EBITDA · FY 2025
₹27.27 Lakh
EBITDA margin 11.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹10.1 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings

About Xlcea Pharmaceutical Private Limited

Data last updated:

Xlcea Pharmaceutical Private Limited is a private limited company based in Gurgaon, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 December 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100HR2020PTC091652. Its GSTIN is 06AAACX3521C1ZV (Haryana).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ajay Partap Singh and Vikash Kumar.

Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1/8 Lg 4 – 8 Marla Model Town, Gurgaon, Haryana, India – 122001.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.3 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹16.25 Lakh (net margin 7.1%) and EBITDA of ₹27.27 Lakh (EBITDA margin 11.9%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years.

As per MCA filings, the company has open charges of ₹10.1 Lakh on record.

Xlcea Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-05-0009309).

Company details

CIN U85100HR2020PTC091652
Registration Number 091652
Incorporation Date 17 December 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-HR-05-0009309

Recognitions & Rankings of Xlcea Pharmaceutical

MSME (Udyam registered) Ministry of MSME
Category
Micro (2020-21)
Udyam number
UDYAM-HR-05-0009309

Contact details

Xlcea Pharmaceutical Private Limited's registered office is in Gurgaon, Haryana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    1/8 Lg 4 – 8 Marla Model Town, Gurgaon, Haryana, India – 122001
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Xlcea Pharmaceutical Private Limited, buy the company report.

Comprehensive company report
Xlcea Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Xlcea Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Xlcea Pharmaceutical Private Limited, buy the company report.

Financials of Xlcea Pharmaceutical Private Limited

FY 2025 filings available

Xlcea Pharmaceutical Private Limited reported revenue of ₹2.3 Cr (down 12% YoY) for FY 2025.

Revenue · FY 2025
₹2.3 Cr ▼ 12%
Net profit · FY 2025
₹16.25 Lakh margin 7.1%
EBITDA · FY 2025
₹27.27 Lakh margin 11.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 12%
3 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▼ 22%
3 years · compounded
▲ 8%

Revenue fell 12% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹27.27 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹16.25 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin11.9%
Net Profit Margin7.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Xlcea Pharmaceutical Private Limited, buy the company report.

Board of directors of Xlcea Pharmaceutical Private Limited

Xlcea Pharmaceutical has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Ajay Partap SinghDirector17 Dec 20205 Years 10 MonthsCurrent
Vikash KumarDirector17 Dec 20205 Years 10 MonthsCurrent

Auditor

Xlcea Pharmaceutical Private Limited is audited by A S Mahalawat & Associates for the financial year 2022.

Auditor firmFinancial yearFirm registration number
A S Mahalawat & AssociatesFY 2022037319N

Shareholding

The shareholding of Xlcea Pharmaceutical Private Limited is on record for FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Xlcea Pharmaceutical Private Limited, buy the company report.

Charges & borrowings

Open charges
₹10.1 Lakh
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹0.10 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Dec 2022100709128Hdfc Bank Limited₹10.1 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Xlcea Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Xlcea Pharmaceutical Private Limited has 1 active EPFO establishment as of Apr 04, 2024.

Active EPFO establishments
1

GST

Xlcea Pharmaceutical has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AAACX3521C1ZVHaryanaActive05 Jan 2021

To see the full GST registrations and return filing status of Xlcea Pharmaceutical Private Limited, buy the company report.

Recent activity

Xlcea Pharmaceutical Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Ajay Partap Singh was appointed as Director on 17 Dec 2020.

AGM
Xlcea Pharmaceutical Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Xlcea Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 10.10 Lakh with Charge ID 100709128 was registered on 30 Dec 2022.
Appointed
Ajay Partap Singh was appointed as Director.
Appointed
Vikash Kumar was appointed as Director.
Incorporation
17 Dec 2020
Xlcea Pharmaceutical Private Limited was registered on 17 Dec 2020 with Roc Delhi & aged 5 years 10 months as per MCA records.

Frequently asked questions

Xlcea Pharmaceutical is an active private limited company based in Gurgaon, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 December 2020 (6+ years old) and is registered under CIN U85100HR2020PTC091652.

Xlcea Pharmaceutical has 2 current directors:

The latest financial statements of Xlcea Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Xlcea Pharmaceutical is 06AAACX3521C1ZV, registered in Haryana.

The CIN (Corporate Identification Number) of Xlcea Pharmaceutical is U85100HR2020PTC091652. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Xlcea Pharmaceutical was incorporated on 17 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.

Ajay Partap Singh was appointed as Director on 17 Dec 2020. Vikash Kumar was appointed as Director on 17 Dec 2020.

Yes, Xlcea Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-05-0009309).

The registered office of Xlcea Pharmaceutical is at 18 Lg 4 – 8 Marla Model Town, Gurgaon, Haryana, India – 122001.

Xlcea Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.